Curetis N.V. | Mutual Funds

Mutual Funds that own Curetis N.V.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
PWM Vermoegensfondsmandat - DWS - High Conviction Equity (EUR)
60,000
0.37%
0
0.25%
07/31/2018
Lupus alpha Fonds - All Opportunities Fund
30,000
0.18%
0
0.1%
12/31/2017
Lupus alpha Fonds - Micro Champions
20,000
0.12%
0
0.16%
12/31/2017
UniSector: BioPharma
0
0%
-215,000
0%
03/31/2018

About Curetis

View Profile
Address
Max-Eyth-Strasse 42
Holzgerlingen Baden Wuerttemberg 71088
Germany
Employees -
Website http://www.curetis.com
Updated 07/08/2019
Curetis NV engages in the manufacture, research and development, and commercialization of molecular microbiology solutions. It offers unyvero platform, which comprsises of the unyvero system with the A50 analyzer at its core, proprietary software, and single-use, application-specific cartridges. The company was founded by Johannes Bacher, Gerd Luedke and Andreas Boos on October 8, 2015 and is headquartered in Holzgerlingen, Germany.